Cannatrek Ltd (LITTLEGRN FPO [LGP]) Aktie

Cannatrek Ltd operates as a vertically integrated business focused on the cultivation, manufacture, and delivery of plant-based medicines, with an emphasis on medicinal cannabis. The company provides plant-based medicines, including medicinal cannabis products, to eligible patients and manages the entire supply chain through cultivation, manufacturing, processing, and distribution services. It offers digital health services such as a prescriber portal for healthcare professionals and engages in research and development, including partnerships with academic institutions for genetic library development and medical cannabis research. The company runs a not-for-profit foundation that provides subsidies to eligible patients and promotes research and education around plant-based medicine. Support services are available for patients and healthcare providers regarding treatment options and product information. The company serves healthcare providers, medical researchers, and eligible patients in the medicinal cannabis sector, and collaborates with international partners in the medical cannabis industry. The company was incorporated in 1992 and is based in Balaclava, Australia.